Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients
Jansen NL, Suchorska B, Wenter V, Eigenbrod S, Schmid-Tannwald C, Zwergal A, Niyazi M, Drexler M, Bartenstein P, Schnell O, Tonn JC, Thon N, Kreth FW, La Fougère C (2014)
Publication Type: Journal article
Publication year: 2014
Journal
Book Volume: 55
Pages Range: 198-203
Journal Issue: 2
DOI: 10.2967/jnumed.113.122333
Abstract
Because the clinical course of low-grade gliomas in the individual adult patient varies considerably and is unpredictable, we investigated the prognostic value of dynamic 18F-fluorethyltyrosine (18FFET) PET in the early diagnosis of astrocytic low-grade glioma (World Health Organization grade II). Methods: Fifty-nine patients with newly diagnosed low-grade glioma and dynamic 18F-FET PET before histopathologic assessment were retrospectively investigated. 18F-FET PET analysis comprised a qualitative visual classification of lesions; assessment of the semiquantitative parameters maximal, mean, and total standardized uptake value as ratio to background and biologic tumor volume; and dynamic analysis of intratumoral 18F-FET uptake over time (increasing vs. decreasing time-activity curves). The correlation between PET parameters and progression-free survival, overall survival, and time to malignant transformation was investigated. Results: 18F-FET uptake greater than the background level was found in 34 of 59 tumors. Dynamic 18F-FET uptake analysis was available for 30 of these 34 patients. Increasing and decreasing time- activity curves were found in 18 and 12 patients, respectively. Neither the qualitative factor presence or absence of 18F-FET uptake nor any of the semiquantitative uptake parameters significantly influenced clinical outcome. In contrast, decreasing time-activity curves in the kinetic analysis were highly prognostic for shorter progression-free survival and time to malignant transformation (P < 0.001). Conclusion: Absence of 18F-FET uptake in newly diagnosed astrocytic low-grade glioma does not generally indicate an indolent disease course. Among the 18F-FET-positive gliomas, decreasing time-activity curves in dynamic 18F-FET PET constitute an unfavorable prognostic factor in astrocytic low-grade glioma and, by identifying high-risk patients, may ease treatment decisions. Copyright © 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Authors with CRIS profile
Involved external institutions
Germany (DE)How to cite
APA:
Jansen, N.L., Suchorska, B., Wenter, V., Eigenbrod, S., Schmid-Tannwald, C., Zwergal, A.,... La Fougère, C. (2014). Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients. Journal of Nuclear Medicine, 55(2), 198-203. https://doi.org/10.2967/jnumed.113.122333
MLA:
Jansen, Nathalie L., et al. "Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients." Journal of Nuclear Medicine 55.2 (2014): 198-203.
BibTeX: Download